Postdoctoral researchers
The ARC Training Centre in Cell and Tissue Engineering Technologies will offer positions for postdoctoral fellows to complete industry-led research and participate in a specially developed training program.
CTET’s research program will train postdoctoral research fellows to drive ground-breaking technologies in order to support the current and future market needs of the tissue engineering and regenerative medicine sector. The business-focused projects will provide the necessary background studies that will catalyse a highly productive commercialisation environment and aid the transition of small-medium enterprises into larger firms.
Accordion content
Dr Ravichandran is a Postdoctoral Research Fellow in the School of Mechanical, Medical and Process Engineering at Queensland University of Technology (QUT), Australia. She graduated from her Bachelors in Bioengineering as the Best Outgoing Student from SASTRA University, India. This was followed by a PhD in the School of Chemical and Biomedical Engineering, Nanyang Technological University (NTU), Singapore. Since June 2018, she has been working in the Centre in Regenerative Medicine group, QUT with Dr. Laura Bray and Prof. Dietmar Hutmacher. Her scientific contributions have advanced the utility of scaffolds, hydrogels, and bioreactors for engineering 3D tissue models. In CTET, she is working with BellaSeno on scaffold-guided breast tissue engineering.
Accordion content
Yaping Chen gained her Ph.D. degree in immunology in 2017 from the School of Biomedical Sciences, Monash University, and has since been a research fellow at the Monash Institute of Pharmaceutical Sciences. She has established an interdisciplinary research program with a focus on both fundamental and applied nano–bio technology. Her research aims to develop novel, smart, and functional nano–bio interfaces for genetic modification and cell engineering, with the ultimate goal of improving current cellular immunotherapy. Within CTET, she is working with ULVAC and Nicholas Voelcker.
CTET will deliver a number of economic and health benefits through the training of students and postdoctoral researchers, including:
- Innovative biomimetic materials and cutting-edge technology solutions for the advanced manufacturing of cell-based or cell-derived products, sensors and monitoring systems for application in bioreactors which will lead to lower cost, more efficient, and more broadly available cell and tissue-based technologies
- Enhanced supply chain capabilities for cell and tissue engineering therapies
- Industry-ready graduates and early career researchers with innovative, translational, cross-disciplinary and entrepreneurial mind-sets
- Enhanced existing and new collaborative engagement between academia and industry leading to globally competitive commercialisation of tissue engineering and regenerative medicine technologies
- Strengthened networks of related Australian and global companies fostering a higher rate of successful collaboration, competitiveness and market access
- Advanced manufacturing and business development scale and capability that attract global investments into Australia
- Greater access of Australian SMEs to capital and investments for product and business development.
